Month: November 2024

Which patients with early-stage breast cancer will benefit most from immunotherapy, and at what point is immunotherapy most useful?This question ...

Adults with diabetes who participated in telehealth visits reported similar levels of care, trust in the healthcare system, and patient-centered ...

WASHINGTON — There is no benefit to interrupting treatment with many of the available targeted synthetic or biologic disease-modifying antirheumatic ...

The FDA has granted fast-track approval for a groundbreaking gene therapy indicated for a rare genetic disorder called aromatic L-amino ...

TOPLINE:Aggressive infliximab dosing regimens – intensified induction or accelerated induction – show similar clinical responses and remission rates as the ...

The US Food and Drug Administration (FDA) has accepted a resubmission of the supplemental Biologics License Application for dupilumab for ...

Nursing is a competitive field. In 2022, nursing schools rejected more than 78,000 qualified applications, and the students whose applications ...

TOPLINE:Early initiation of biologic therapy in patients with Crohn’s disease (CD) is associated with higher rates of transmural healing and ...

TOPLINE:Brief cognitive behavioral therapy (BCBT) even when delivered remotely via video telehealth effectively reduces suicide attempts among high-risk adults. METHODOLOGY:The researchers ...

SEATTLE — A novel, quick, and low-cost dementia screening test could significantly improve early detection of Alzheimer's disease in primary ...

WASHINGTON — Women with rheumatoid arthritis (RA) experience improved fertility when treated using a treat-to-target (T2T) approach aimed at remission, ...

VANCOUVER, BRITISH COLUMBIA — Amid a lack of consensus on screening men for prostate cancer using the prostate-specific antigen (PSA), ...

LISBON, Portugal — “Work together and mobilize our forces” around the Pandemic Treaty, said experts at the 17th European Public ...

Sacubitril-valsartan, a common drug combination for heart failure, cuts the risk for cardiomyopathy after chemotherapy in patients who received anthracycline ...

Muvalaplin, a novel oral medication, safely and effectively lowers high levels of lipoprotein(a), or Lp(a), results from the phase 2 ...

CHICAGO -- Secondhand permanent pacemaker use in poorer countries, following thorough cleaning and repackaging, has not resulted in patient harm ...

CHICAGO -- The novel myeloperoxidase (MPO) inhibitor mitiperstat failed to improve quality of life or functional capacity in heart failure ...

Several hundred primary care physicians at Mass General Brigham (MGB) notified the National Labor Relations Board on Friday that they ...

One of the leading public health associations came out Monday against President-elect Trump's nomination of vaccine skeptic Robert F. Kennedy ...

Members of the Healthcare Infection Control Practices Advisory Committee (HICPAC) voted Friday to defend what some have called weak standards ...